NCT01002274View on ClinicalTrials.gov

Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms

PHASE3CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Lower Urinary Tract SymptomsBenign Prostatic Hyperplasia
Interventions
DRUG

MCS-2

2 soft-gel capsules Qd for 40 weeks

Trial Locations (1)

Unknown

National Taiwan University Hospital, Taipei

Sponsors
All Listed Sponsors
lead

Health Ever Bio-Tech Co., Ltd.

INDUSTRY